Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis.
Analysts forecast the Active Pharmaceutical Ingredients market in the US to grow at a CAGR of 7.01 percent over the period 2014-2019.
The report covers the present scenario and the growth prospects of the API market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. It provides the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The market segmentation is carried out on the basis of: type of production process (synthetic production process and biotechnology-based production process), type of product (conventional API and high-potency API), and type of players (captive and merchant).
The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
API Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
- Abbott Laboratories
- Aurobindo Pharma
- Teva Pharmaceutical Industries
Other Prominent Vendors
- Boehringer Ingelheim
- Dr. Reddy’s Laboratories
- Lonza Group
- Sun Pharmaceutical Industries
- Strong Preference for Generic Drugs
- Decrease in R&D Spending
- Strong Focus on High-potency API
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=31089 .
(Prices start at US $2500 for a single user PDF)
Scars are treated using both invasive techniques such as surgery and non-invasive techniques such as OTC treatment products. These products and procedures are used to treat all types of scars, such as keloid scars, contracture scars, hypertrophic scars, and atrophic scars. Scars caused by surgery can be removed by surgical revisions, although most people are reluctant to go for another invasive procedure after a surgery.
A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs.